The results of the Department of Defense's breast lymphatic mapping study

Annals of Surgical Oncology

Volumn 9, Issue 5, 2002, Pages 428-429

  Litvak, David A ^a,b   Guiliano, Armondo E ^a,b  

^a Joyce Eisenberg Keefer Breast Center   (United States)

^b JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST BIOPSY; BREAST CANCER; BREAST SURGERY; EDITORIAL; HUMAN; LYMPH NODE DISSECTION; LYMPHATIC SYSTEM; MEDICAL SOCIETY; PROGNOSIS; SENTINEL LYMPH NODE;

AXILLA; BREAST NEOPLASMS; FEMALE; HOSPITALS, COMMUNITY; HOSPITALS, UNIVERSITY; HUMANS; LYMPHATIC METASTASIS; MILITARY PERSONNEL; MULTICENTER STUDIES; NEOPLASM STAGING; PROFESSIONAL COMPETENCE; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 0036282569     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2002.9.5.428     Document Type: Editorial

References (7)

1. Final results of the department of defense multicenter breast lymphatic mapping trial
2. The sentinel node in breast cancer - A multicenter validation study
3. Sentinel lymph node biopsy for breast cancer: A suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used
4. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer
5. Sentinel lymph node detection for breast cancer: Which patients are best suited for the patent blue dye only method of identification?
6. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
7. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?